This page shows ARK 21Shares Bitcoin ETF (ARKB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Tiny operating costs sit beside large valuation-driven earnings swings, so this vehicle is governed mainly by asset values.
From FY2024 to FY2025, operating loss stayed small, moving only from-$5.8M to-$9.8M . Yet net income flipped from$1.89B to-$222.3M , which implies reported earnings are dominated by changes in the underlying asset values while the ongoing cost base remains comparatively minor.
The balance sheet stayed lightly encumbered: FY2025 liabilities were
ROA and ROE were nearly identical in both years, around
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of ARK 21Shares Bitcoin ETF's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
ARK 21Shares Bitcoin ETF carries a low D/E ratio of 0.02, meaning only $0.02 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
ARK 21Shares Bitcoin ETF's ROE of -6.7% shows moderate profitability relative to equity, earning a score of 38/100. This is down from 43.5% the prior year.
Key Financial Metrics
Earnings & Revenue
ARK 21Shares Bitcoin ETF reported -$222.3M in net income in fiscal year 2025. This represents a decrease of 111.8% from the prior year.
Cash & Balance Sheet
Margins & Returns
ARK 21Shares Bitcoin ETF's ROE was -6.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 50.2 percentage points from the prior year.
Capital Allocation
ARKB Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -$1.4M+33.8% | -$2.2M+21.3% | -$2.8M-13.5% | -$2.4M-3.3% | -$2.4M-10.6% | -$2.1M-41.8% | -$1.5M+3.0% | -$1.6M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$716.8M+37.7% | -$1.2B-462.0% | $317.7M-73.5% | $1.2B+303.8% | -$587.5M-141.7% | $1.4B+2959.1% | $46.1M+111.3% | -$409.2M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ARKB Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.4B-29.3% | $3.4B-34.9% | $5.2B+3.1% | $5.0B+28.1% | $3.9B-9.7% | $4.4B+35.7% | $3.2B+11.0% | $2.9B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.2M-98.4% | $76.6M-27.7% | $105.9M+920.3% | $10.4M-56.6% | $23.9M+106.6% | $11.6M+9.6% | $10.6M-78.1% | $48.4M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $2.4B-27.7% | $3.3B-35.1% | $5.1B+1.2% | $5.0B+28.6% | $3.9B-10.0% | $4.4B+35.8% | $3.2B+12.5% | $2.8B |
| Retained Earnings | $952.5M-42.9% | $1.7B-40.8% | $2.8B+12.7% | $2.5B+91.8% | $1.3B-31.1% | $1.9B+292.9% | $481.5M+10.6% | $435.4M |
ARKB Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | -30.0%+4.8pp | -34.8%-41.0pp | 6.2%-17.5pp | 23.8%+38.8pp | -15.0%-47.4pp | 32.4%+31.0pp | 1.4%+15.8pp | -14.4% |
| Return on Assets | -30.0%+4.0pp | -34.0%-40.1pp | 6.1%-17.6pp | 23.7%+38.6pp | -14.9%-47.2pp | 32.3%+30.9pp | 1.4%+15.6pp | -14.1% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.00-0.0 | 0.020.0 | 0.02+0.0 | 0.000.0 | 0.010.0 | 0.000.0 | 0.00-0.0 | 0.02 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |